Supporting a Next-Gen Blood Pressure Monitor for FDA 510(k) and EU MDR Validation

A digital health company developed a new generation of automated, cuff-based blood pressure monitors (BPMs) with Bluetooth capability and companion mobile app integration. As a Class II medical device, clinical validation was essential for FDA 510(k) clearance and EU MDR certification.

Client Challenges

Clinvigilant Research Solution

Study Design & Regulatory Mapping

Site Selection & Participant Management

Data Capture & Device Evaluation

Quality Control & Reporting

Outcomes

112

Subjects Enrolled

High inter-rater reliability

(ICC > 0.95)

Repeatability

<1%

Connectivity/Data Sync Errors

Within 3 weeks post DB lock

Time to 510(k) Submission

<±5 mmHg vs. reference

(meets ISO standard)

Device Accuracy
(Mean ± SD)

CER accepted with no technical file gaps

EU MDR Audit Outcome

89/100 (Excellent)

High inter-rater reliability (ICC > 0.95)

Outcomes

Subjects Enrolled 112

Device Accuracy (Mean ± SD) <±5 mmHg vs. reference (meets ISO standard)

Repeatability High inter-rater reliability (ICC > 0.95)

EU MDR Audit Outcome CER accepted with no technical file gaps

Connectivity/Data Sync Errors <1%

Time to 510(k) Submission Within 3 weeks post DB lock

High inter-rater reliability (ICC > 0.95) 89/100 (Excellent)

Client Testimonial

VP of Product Development
Digital Health Company

“Clinvigilant delivered a seamless and scientifically robust study that made our FDA and MDR pathways smooth. Their attention to regulatory detail and real-world data capture was critical.”

Results?

With Clinvigilant’s clinical and regulatory expertise, the sponsor was able to confidently validate and submit a next-generation blood pressure monitoring system to global regulators — supported by a high-quality dataset, integrated device and app analytics, and comprehensive clinical reporting.

Would you like this case study exported as:

  • A professionally branded PDF or slide deck?
  • A Regulatory Summary Brief for FDA/EU MDR submission files?
  • A public-facing version for press releases or website?

Let me know your preferred format, and I’ll get it ready for you!

Ready to working with All-In-One CRO?

Together, We Accelerate Breakthroughs – Bringing New Treatments to Patients Faster